Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Stephen (Steve) Griffin

Stephen (Steve) Griffin is recorded as CEO and Board Member at Anika Therapeutics, Inc. (ANIK). Anika Therapeutics, Inc. reported in an 8-K filed January 8, 2026 that Stephen (Steve) Griffin was appointed member of the Board of Directors, effective February 1, 2026. Anika Therapeutics, Inc. reported in an 8-K filed January 8, 2026 that Stephen (Steve) Griffin was appointed President and Chief Executive Officer, effective February 1, 2026.

“Stephen (Steve) Griffin, current Executive Vice President, Chief Financial Officer and Chief Operating Officer, has been appointed President and Chief Executive Officer and a member of the Board of Directors, effective February 1, 2026.”
Anika Therapeutics, Inc. Form 8-K, filed January 8, 2026 · Read the filing
“Stephen (Steve) Griffin, current Executive Vice President, Chief Financial Officer and Chief Operating Officer, has been appointed President and Chief Executive Officer and a member of the Board of Directors, effective February 1, 2026.”
Anika Therapeutics, Inc. Form 8-K, filed January 8, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Anika Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.